Small cell lung cancer - Chemotherapy as treatment of primary and recurrent metastic disease;Carcinoma pulmonar de pequenas células - quimioterapia como tratamento da doença disseminada primária e recidivante

Revista Portuguesa de Pneumologia

Volumn 8, Issue 4, 2002, Pages 341-349

  Barata, Fernando José ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Brain metastases second line treatment; Chemotherapy; Elderly lung cancer; Extensive disease; Maintenance therapy; Small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHENAMINE; METHOTREXATE; NAVELBINE; NIMUSTINE; PACLITAXEL; PLATINUM; TENIPOSIDE; TOPOTECAN; VINCRISTINE; VINDESINE;

ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; HUMAN; LONG TERM CARE; LUNG SMALL CELL CANCER; METASTASIS; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; QUALITY OF LIFE;

EID: 0036660861     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30771-6     Document Type: Article

References (40)

1. ARDIZZONI A, HANSEN H et al - Topotecan, a new active drug in second line treatment os small cell lung cancer - a phase II study in patients with refractory and sensitive disease. J Clin Oncol 1997;15:2090-2096
2. BAJORIN DF, SAROSDY et al - Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with small cell ling cancer. J Clin Oncol 1993; 11:598-606
3. CLAMOM GH, AUDEH MW et al - Small cell lung cancer in elderly. J Am Geriat Soc 1992;30:299-303
4. DEPPERMAN KM - Influence of age and comorbidities on the chemotherapeutic management of lung cancer. Lung Cancer 2001;33:S115-S120
5. DEVORE RF, JOHNSON DH - Chemotherapy for small Cell Lung Cancer in Lung Cancer - Lippincott Williams and Wilkins, 2000;58:922-939
6. EBI NK, HOJO F et al. - Second line chemotherapy for relapsed small cell lung cancer. J Clin Oncol 1997;27:166-171
7. ETTINGER DS, FINKELSTEIN DM et al - A randomized comparision of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive stage small cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol 1990;8:230-240.
8. ETTINGER DS - Evaluation of new drugs in untreated patients with small cell lung cancer. J Clin Oncol 1990;8: 374-380
9. EVANS W, SHEPHERD et al - VP-16 and cisplatin as first line therapy for extensive small cell lung cancer. J Clin Oncol 1985;3:1471-1477
10. EVANS W, SHEPHERD et al - VP-16, ifosfamide and cisplatin for extensive small cell lung cancer. Eur J Cancer 1994;30A:299-303
11. EUROPEAN LUNG CANCER WORKING PARTY - MASCAUX C, PAESMAN M et al. - A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000;30:23-36
12. FINDLAY MP, GRIFFIN AM et al - Retrospective review of chemoterapy for small cell lung cancer in the elderly. Eur J Cancer 1991;27:1597-1601
13. GIACCONE G, DALESIO O et al - Maintenance chemotherapy in small cell lung cancer: long term results of a randomized trial. J Clin Oncol 1993;11:1230-1240.
14. GILLENWATER HH, SOCINSKI MA - Extensive Stage Small Cell Lung Cancer - in Diagnosis and Treatment of Lung Cancer - 2001, 360-375
15. GIRLING DJ. - Comparison of oral etoposide and standart intravenous multidrug chemotherapy for small cell lung cancer. A stopped multicentre randomized trial - Lancet 1996; 348: 563-566
16. IHDE DC - Small cell lung cancer state of the art therapy. Chest 1995; 107: 243-248.
17. JETT J, DAY R et al - Topotecan and paclitaxel in extensive small cell lung cancer. Lung Cancer 1997; 18: 13A
18. JOHNSON DH, EINHORN LH et al - A randomized camparison of high-dose versus convencional dose for extensive stage small cell lung cancer: a phase III trial of Southeastern Cancer Study Group. J Clin Oncol 1987;5: 1731-1738
19. JOHNSON DH - Investigation of new agents in small cell lung cancer. Chest 1993;103:423S
20. KELLY K. - New chemotherapy agents for small cell lung cancer. Chest 2000; 117: 152-162.
21. KLASA RJ, MURRAY N et al - Dose-intensity meta-analysis of chemotherapy regimens in small cell carcinoma. J Clin Oncol 1991;9:499-508
22. KOSMAS C et al - Phase II study of paclitaxel, ifosfamide e cisplatin as second line treatment in relapsed small cell lung cancer. J Clin Oncol 2001;19: 119-126
23. KRISTENSEN AS, HANSEN HH et al - Systemic chemotherapy of brain metastases of small cell lung cancer - a review. J Clin Oncol 1992;10:1498-1502.
24. LOEHRER PJ, ANSARI R et al - Cisplatin plus etoposide with or without ifosfamide in extensive small cell lung cancer: a Hoosier Oncology Group Study. J Clin Oncol 1995; 13: 2594-2599
25. LEOHRER PJ, RYNARD S et al - Etoposide, ifosfamide and cisplatin in extensive small cell lung cancer. Cancer 1992;69:669-673
26. LOWENBRAUN S, BARTOLUCCI A et al - The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma. Cancer 1979; 44:406-413
27. MURRAY N, LIVINGSTON RB et al - Randomized study of CODE versus alternating CAV/EP for extensive stage small cell lung cancer. Na intergroup study of National Cancer Institute of Canada Clinical Trials Group and South West Oncology Group. J Clin Oncol 1999;17:2300-2308
28. NUSSBAUM ES, DJALILIAN HR et al - Brain metastases. Histology, multiplicity, survival. Cancer, 1996;78:1781-1788
29. POSTMUS PE, SCAGLIOTTI G et al - Standart versus alternating non-cross resistant chemotherapy in extensive small cell lung cancer: na EORTC phase III trial. Eur J Cancer 1996; 32A: 1498-1503
30. ROTH BJ, JOHNSON DH et al - Randomized study of cyclophosphamide, doxorubicin and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small cell lung cancer: a phase III trial of the South-Eastern Cancer Study Group. J Clin Oncol 1992; 10:282-291
31. SCULIER JP, PAESMAN M et al - Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small cell lung cancer. J Clin Oncol 1996;14:2337-2344
32. SCULIER JP, BERGHMANS T et al - Maintenance chemotherapy for small cell lung cancer- a critical review. Lung Cancer 1998;19:141-151
33. SHEPHERD FA, BEZJAK et al - Treatment of small cell lung cancer in elderly patient. In: Pass H et col, editors. Lung Cancer. Philadelphia, USA: Lippincott Williams & Wilkins, 2000
34. SKARLOS CV, SAMANTAS E et al - Randomized comparsion os etoposide-cisplatin vs etoposide-carboplatin and irradiation in small cell lung cancer. A Hellenic Cooperative Oncology Group Study. Ann Oncol 1994; 5:601-607
35. SMITH IE, PERREN TJ et al - Carboplatin, etoposide and ifosfamide as intensive chemotherapy for small cell lung cancer. J Clin Oncol 1990;8:899-905.
36. SHUETTE W - Chemotherapy as treatment of primary and recurrent small lung cancer. Lung Cancer 2001; 33 (Supl 1):S99-S107
37. SPIROS, SOUHAMI R et al - Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign Trial. Br J Cancer 1989;59:578-583.
38. URBAN T, BALEYTE T et al - Standart combination versus alternating chemotherapy in small cell lung cancer: a randomised clinical trial including 394 patients. Lung Cancer 1999;25:105-113
39. WILLIAMS C, ALEXANDER M et al - Role of Radiation therapy in combination with chemotherapy in extensive oat cell cancer of lung: a randomized study. Cancer Treat Resp 1977;61:1427-1431
40. WOLF M. - Dose intensive chemotherapy in small cell lung cancer. Lung Cancer 2001; 33: S125-135